Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Clinical and research progress continues alongside substantial cost reductions. Conference Call Today at 4:30 p.m. ET SAN DIEGO, Nov. 12, 2025 /PRNewswire/ — Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks